Surgimend
Device Recon-Skin And Wound
PDI 10381780357391
General payments
$854,279
Research payments
$50,374
Through program year 2025, $854,279 in general payments and $50,374 in research payments were reported against Surgimend (Recon-Skin And Wound).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $270,922 | 3,047 |
| 2024 | General | $216,609 | 2,389 |
| 2024 | Research | $15,250 | 1 |
| 2023 | General | $131,669 | 1,890 |
| 2023 | Research | $20,604 | 2 |
| 2022 | General | $93,380 | 2,046 |
| 2022 | Research | $14,520 | 1 |
| 2021 | General | $141,699 | 1,295 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 74 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,667 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.